NCT01397994View on ClinicalTrials.gov

Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.

PHASE4UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Chronic Stable Angina
Interventions
DRUG

Nicorandil

Patients would be advised 10mg bd nicorandil for the first seven days. Drug will be titrated to 20 mg bd after one week, atenolol 50 mg will be given along with nicorandil from day 1

DRUG

Atenolol

Patients in the control arm would be advised atenolol 50 mg od

Trial Locations (1)

75850

RECRUITING

National Institute of Cardiovascular Diseases, Karachi

Sponsors
All Listed Sponsors
lead

Ferozsons Laboratories Ltd.

INDUSTRY

NCT01397994 - Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina. | Biotech Hunter | Biotech Hunter